Xie C, Huang W, Sun Y, Xiang C, Trahair L, Jones KL, et al
in-house studies may have bias unless independently replicated
[21] Patients with a history of pancreatitis, severe gastrointestinal conditions, or significant renal impairment would require careful individual clinical assessment before any future prescribing consideration, in line with the relevant UK SmPCs
Similarly, GIP infusion i.v
While oral formulations are emerging, injectable solutions continue to lead due to their established clinical success in managing blood glucose levels, providing healthcare providers with reliable options for managing T2DM and obesity in patients requiring stable, consistent dosing
Chronic fatigue, post-viral exhaustion, adrenal burnout, or just running on empty